Top Story

High-dose melphalan plus ASCT significantly extended survival in newly diagnosed myeloma

September 23, 2014

Consolidation with high-dose melphalan plus autologous stem-cell transplantation significantly prolonged PFS and OS with in patients with newly diagnosed myeloma compared with melphalan, prednisone and lenalidomide, according to results of randomized, open-label phase 3 study.

Lenalidomide maintenance significantly extended PFS in this patient population regardless of the consolidation regimen, results showed.

figure Meeting News CoverageVideo

Radiation noninferior to axillary lymph node dissection for SLNB-detected N1 disease

September 22, 2014
SAN FRANCISCO — Yun Fu, MD, of the department of breast surgery at Shanghai First Maternity and Infant Hospital, discusses study results that showed that…
Meeting News Coverage

TEDMED: Sensor technology helps test hands-on skills

September 22, 2014
After witnessing a colleague miss a blood clot in a patient with acute coronary syndrome, Carla M. Pugh, MD, PhD, FACS, recognized the need for a tool to measure the…
In the Journals

Cirrhotic LT candidates showed increased risk for colorectal neoplasia

September 22, 2014
Patients awaiting liver transplant with alcoholic or viral cirrhosis had greater risk for developing colorectal neoplasia than healthy controls, according to new study…
More News Headlines »
Pharmacology Consult Publication Exclusive
figure

Emerging data will determine role of ramucirumab in treatment of advanced gastric cancer

HemOnc Today, July 25, 2014
Van Nguyen, PharmD, BCOP
Despite current therapies, gastric cancer remains the second leading cause of cancer-related mortality worldwide…
More »
Meeting News Coverage Video
figure

Radiation noninferior to axillary lymph node dissection for SLNB-detected N1 disease

September 22, 2014
SAN FRANCISCO — Yun Fu, MD, of the department of breast surgery at Shanghai First Maternity and Infant Hospital…
More »